LifeCodexx's Corporate Majority Round

LifeCodexx raised a round of funding on July 27, 2017. Investors include Eurofins Scientific.

LifeCodexx develops clinically validated non-invasive diagnostic tests based on the newest molecular analytical methods. PrenaTest® is a non-invasive prenatal test for the determination of the most c…

Articles about LifeCodexx's Corporate Majority Round: